Fennec Pharmaceuticals (FENC) Free Cash Flow (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Free Cash Flow of -$6.0 million for Q4 2025, down 499.33% on a QoQ basis from $1.5 million in Q3 2025, and down 304.48% year-over-year from $2.9 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Free Cash Flow (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Free Cash Flow history runs 16 years deep, the most recent figure standing at -$6.0 million for Q4 2025.
- Quarterly Free Cash Flow fell 304.48% year-over-year to -$6.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.5 million (down 149.42% YoY) and the FY2025 annual result came in at -$15.3 million, down 156.58% from the prior year.
- Free Cash Flow was -$6.0 million for Q4 2025 at Fennec Pharmaceuticals, down from $1.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $37.3 million in Q1 2024 and bottomed at -$8.4 million in Q2 2024.
- A 5-year average of -$1.8 million and a median of -$3.6 million in 2021 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2024 — Free Cash Flow surged 768.94% — and 2025, when it slumped 304.48%.
- Fennec Pharmaceuticals' Free Cash Flow stood at -$3.2 million in 2021, then tumbled by 109.61% to -$6.8 million in 2022, then advanced by 28.55% to -$4.9 million in 2023, then jumped by 69.67% to -$1.5 million in 2024, then slumped by 304.48% to -$6.0 million in 2025.
- Business Quant data shows FENC's Free Cash Flow at -$6.0 million in Q4 2025, $1.5 million in Q3 2025, and -$3.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.96 Mn |
| Dec 31, 2025 | -5.96 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | -2.21 Mn |
| Sep 30, 2024 | -2.21 Mn |
| Jun 30, 2024 | -8.39 Mn |
| Jun 30, 2024 | -8.39 Mn |
| Mar 31, 2024 | 37.31 Mn |
| Mar 31, 2024 | 37.31 Mn |
| Dec 31, 2023 | -4.86 Mn |
| Dec 31, 2023 | -4.86 Mn |
| Sep 30, 2023 | -2.76 Mn |
| Sep 30, 2023 | -2.76 Mn |